96 related articles for article (PubMed ID: 22233283)
1. Efficacy and safety of topical antifungals in the treatment of dermatomycosis: a systematic review.
Rotta I; Sanchez A; Gonçalves PR; Otuki MF; Correr CJ
Br J Dermatol; 2012 May; 166(5):927-33. PubMed ID: 22233283
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical antifungals in the treatment of dermatophytosis: a mixed-treatment comparison meta-analysis involving 14 treatments.
Rotta I; Ziegelmann PK; Otuki MF; Riveros BS; Bernardo NL; Correr CJ
JAMA Dermatol; 2013 Mar; 149(3):341-9. PubMed ID: 23553036
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of topical antifungal drugs in different dermatomycoses: a systematic review with meta-analysis.
Rotta I; Otuki MF; Sanches AC; Correr CJ
Rev Assoc Med Bras (1992); 2012; 58(3):308-18. PubMed ID: 22735222
[TBL] [Abstract][Full Text] [Related]
4. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis.
Korting HC; Kiencke P; Nelles S; Rychlik R
Am J Clin Dermatol; 2007; 8(6):357-64. PubMed ID: 18039018
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review.
van Zuuren EJ; Fedorowicz Z; El-Gohary M
Br J Dermatol; 2015 Mar; 172(3):616-41. PubMed ID: 25294700
[TBL] [Abstract][Full Text] [Related]
6. Oral antifungal-exacerbated inflammatory flare-up reactions of dermatomycosis : case reports and review of the literature.
Nikkels AF; Nikkels-Tassoudji N; Piérard GE
Am J Clin Dermatol; 2006; 7(5):327-31. PubMed ID: 17007544
[TBL] [Abstract][Full Text] [Related]
7. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB
J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
[TBL] [Abstract][Full Text] [Related]
9. [Oral Antifungal Drugs in the Treatment of Dermatomycosis].
Tsunemi Y
Med Mycol J; 2016; 57(2):J71-5. PubMed ID: 27251319
[TBL] [Abstract][Full Text] [Related]
10. Tavaborole, Efinaconazole, and Luliconazole: Three New Antimycotic Agents for the Treatment of Dermatophytic Fungi.
Saunders J; Maki K; Koski R; Nybo SE
J Pharm Pract; 2017 Dec; 30(6):621-630. PubMed ID: 27488125
[TBL] [Abstract][Full Text] [Related]
11. [Present state and future direction of topical antifungals].
Watanabe S
Nihon Ishinkin Gakkai Zasshi; 1999; 40(3):151-5. PubMed ID: 10423509
[TBL] [Abstract][Full Text] [Related]
12. An overview of topical antifungal therapy in dermatomycoses. A North American perspective.
Gupta AK; Einarson TR; Summerbell RC; Shear NH
Drugs; 1998 May; 55(5):645-74. PubMed ID: 9585862
[TBL] [Abstract][Full Text] [Related]
13. Advances in topical and systemic antifungals.
Zhang AY; Camp WL; Elewski BE
Dermatol Clin; 2007 Apr; 25(2):165-83, vi. PubMed ID: 17430754
[TBL] [Abstract][Full Text] [Related]
14. Terbinafine. An update of its use in superficial mycoses.
McClellan KJ; Wiseman LR; Markham A
Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
[TBL] [Abstract][Full Text] [Related]
16. Topical cyclosporine for atopic keratoconjunctivitis.
González-López JJ; López-Alcalde J; Morcillo Laiz R; Fernández Buenaga R; Rebolleda Fernández G
Cochrane Database Syst Rev; 2012 Sep; (9):CD009078. PubMed ID: 22972132
[TBL] [Abstract][Full Text] [Related]
17. The Role of Naftifine HCl 2% Gel and Cream in Treating Moccasin Tinea Pedis.
Vlahovic TC
J Drugs Dermatol; 2016 Feb; 15(2 Suppl):s56-9. PubMed ID: 26885800
[TBL] [Abstract][Full Text] [Related]
18. New Antifungal Agents and New Formulations Against Dermatophytes.
Gupta AK; Foley KA; Versteeg SG
Mycopathologia; 2017 Feb; 182(1-2):127-141. PubMed ID: 27502503
[TBL] [Abstract][Full Text] [Related]
19. Efinaconazole Topical Solution, 10% Efficacy in Patients with Onychomycosis and Coexisting Tinea Pedis.
Markinson B; Caldwell B
J Am Podiatr Med Assoc; 2015 Sep; 105(5):407-11. PubMed ID: 26429609
[TBL] [Abstract][Full Text] [Related]
20. The use of itraconazole to treat cutaneous fungal infections in children.
Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
